Holen Sie sich die Stockscreener-App
13.84
0.36%
0.05
Handel nachbörslich:
13.84
Schlusskurs vom Vortag:
$13.79
Offen:
$13.84
24-Stunden-Volumen:
999.94K
Relative Volume:
0.62
Marktkapitalisierung:
$2.10B
Einnahmen:
$113.31M
Nettoeinkommen (Verlust:
$-57.51M
KGV:
-10.18
EPS:
-1.36
Netto-Cashflow:
$-20.55M
1W Leistung:
-6.49%
1M Leistung:
+64.57%
6M Leistung:
+125.41%
1J Leistung:
+145.39%
1-Tages-Spanne:
$13.42
$13.90
1-Wochen-Bereich:
$13.14
$14.77
52-Wochen-Spanne:
$3.50
$15.92
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Wave Life Sciences (WVE) to Release Earnings on Tuesday - MarketBeat
Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 - StockTitan
B. Riley Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $22.00 - MarketBeat
Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance
Emerald Advisers LLC Purchases 388,280 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences' (WVE) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Those who invested in Wave Life Sciences (NASDAQ:WVE) three years ago are up 195% - Simply Wall St
Wave Life Sciences Highlights Growing Pipeline at Research - GlobeNewswire
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs - StockTitan
How to play biotech stocks: Insmed and Wave Life Sciences - Yahoo Finance
Analysts Set Wave Life Sciences Ltd. (NASDAQ:WVE) Target Price at $19.44 - MarketBeat
Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know - Yahoo Finance
(WVE) Technical Data - Stock Traders Daily
Wave Life Sciences stock slides 31% after company prices $100 million secondary share offering - MSN
Can Wave Life Sciences Make Waves With Forward-53 DMD Trial Data? - RTTNews
Asia Deal Watch: Cureverse Licenses Option For Neurology Candidate To Angelini - Scrip
WAVE Life Sciences (STU:1U5) Growth Rank : 2 (As of Oct. 25, 2024) - GuruFocus.com
WaVe Life Sciences' SWOT analysis: RNA editing pioneer's stock faces pivotal trials - Investing.com India
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Moody Aldrich Partners LLC - MarketBeat
1 Brand-New Big Reason to Buy This Biotech Stock Right Now - Yahoo Finance
VRTX: 3 Pharma Stocks to Watch as Gene Therapy Gains Momentum - StockNews.com
What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now? - Yahoo Finance
RBC Capital raises WAVE Life Sciences stock target By Investing.com - Investing.com Australia
Venture funds, a new chapter for MS & Wave’s data: a BioCentury podcast - BioCentury
Wave Life Sciences (NASDAQ:WVE) PT Raised to $15.00 at Royal Bank of Canada - MarketBeat
Wave Life Sciences Rockets 70% on Historic RNA Editing Success - MSN
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? - Benzinga
SG Americas Securities LLC Has $300,000 Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data - MSN
Insider Sale: President and CEO Paul Bolno Sells 90,474 Shares o - GuruFocus.com
Wave Life Sciences' Chris Francis sells $2.86 million in shares By Investing.com - Investing.com Australia
Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Paul Bolno Sells 90,474 Shares - MarketBeat
Wave Life Sciences CEO Paul Bolno sells $1.36 million in shares By Investing.com - Investing.com South Africa
Wave Life Sciences CEO Paul Bolno sells $1.36 million in shares - Investing.com
Wave Life Sciences' Chris Francis sells $2.86 million in shares - Investing.com
Leerink Partnrs Analysts Raise Earnings Estimates for WVE - MarketBeat
Wave Life Sciences Rockets 70% On Historic RNA Editing Success - Barchart
WVE (WAVE Life Sciences) Change In Inventory : $0.0 Mil (TTM As of Jun. 2024) - GuruFocus.com
WVE (WAVE Life Sciences) Earnings per Share (Diluted) : $-0.57 (TTM As of Jun. 2024) - GuruFocus.com
Wave Life Sciences (NASDAQ:WVE) Shares Gap DownHere's What Happened - MarketBeat
Wave Life Sciences Shares Surge After RNA Editing Discovery - Yahoo Finance
JPMorgan Chase & Co. Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $17.00 - MarketBeat
Wave claims first clinical RNA editing title in rare genetic disease - BioPharma-Reporter.com
Takeda terminates deal with Wave - The Pharma Letter
Wave Life Sciences (NASDAQ:WVE) Receives Buy Rating from HC Wainwright - MarketBeat
WAVE Life Sciences stock's Buy rating and price target reaffirmed by H.C. Wainwright - Investing.com UK
Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last? - Yahoo Finance
WVE Stock Soars 74% as Wave Life Sciences Achieves RNA Editing Breakthrough - MoneyCheck
Wave surges on first RNA editing data in humans - pharmaphorum
Wave data propel RNA-editing stocks, but are all platforms created equal? - BioCentury
WAVE Life Sciences (FRA:1U5) 50-Day SMA : €5.85 (As of Oct. 16, 2024) - GuruFocus.com
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Wave Life Sciences Ltd-Aktie (WVE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Francis Chris | See Remarks |
Oct 16 '24 |
Sale |
13.67 |
208,836 |
2,855,051 |
0 |
| BOLNO PAUL | President and CEO |
Oct 16 '24 |
Sale |
15.00 |
90,474 |
1,357,110 |
268,585 |
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):